Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

The Price is Life for Vital HIV Test

Published: Thursday, October 03, 2013
Last Updated: Thursday, October 03, 2013
Bookmark and Share
Paving the way for better HIV treatment in the world’s least-developed countries.

Cambridge Consultants is working with Médecins Sans Frontières (MSF) to help support moves to expand access to vital diagnostic tests, which paves the way for better treatment of HIV in some of the world’s least-developed countries.

The product development and technology consulting firm is helping MSF’s efforts to widen access to HIV viral load tests by exploring the relative costs of the technologies underpinning a range of viral load assays. These tests are designed for HIV-infected patients undergoing antiretroviral therapy and measure the number of HIV viral particles in patients’ blood.

Viral load testing is the gold standard for HIV treatment monitoring, as it can accurately and quickly detect whether antiretroviral treatment is working. Regular monitoring ensures treatment continues to be effective and patients are adhering to their therapy regime. The World Health Organisation strongly recommends the use of regular viral load monitoring in developing countries.

James Blakemore, senior consultant at Cambridge Consultants, said: “Price and complexity have so far hindered the rollout of these life-saving tests in developing countries. Our work with MSF allows us to share our understanding of the relative costs of assay technologies employed in both central laboratories and point-of-care environments.”

Teri Roberts, diagnostics adviser at MSF, said: “Viral load testing is the best way to ensure treatments are working for patients. It enables timely switching to a more effective drug regimen quickly and accurately before further drug resistance mutations accumulate and reduce the efficacy of second and third-line regimens. The test also helps keep people on more affordable drugs for as long as possible, as targeted and enhanced adherence support – triggered by a detectable viral load – may help keep patients on existing regimens. Working with Cambridge Consultants to analyse key technology options is allowing us to settle on a fair price for a high-quality viral load test.”

Cambridge Consultants is assessing the relative cost per HIV viral load test based on different technologies – analysing costs from reagents, packaging and labelling, as well as manufacturing and intellectual property considerations.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Era in Cancer Diagnostics
Novel development for improved cancer diagnosis and treatment monitoring.
Tuesday, June 04, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos